• Public pharmaceutical expenditure as % of total pharmaceutical expenditure (Line chart)
  • Public pharmaceutical expenditure as % of total pharmaceutical expenditure (Bar chart)
  • Public pharmaceutical expenditure as % of total pharmaceutical expenditure (Boxplot chart)
Data set notes
European Health for All database

Indicators: 618
Updated: 04 September 2022

The following abbreviations are used in the indicator titles:
•    SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)
•    FTE: full-time equivalent
•    PP: physical persons
•    PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes
Public pharmaceutical expenditure as % of total pharmaceutical expenditure
Indicator code: E992709.T

The publicly financed share of total pharmaceutical expenditure. See 992708 above.

The OECD Health Database is used as the primary data source for those countries that are OECD Member States._
Country/Area notes
Ministry of Health. Health insurance institute.
Data are not available.
Expenditure on pharmaceuticals includes expenditure on other medical non-durables (corresponds to
Source: National Institute for Health Insurance / calculations made by the Federal Public Service
Social Security.
Bosnia and Herzegovina
National Health Account of B&H; http://www.who.int/nha/country/bih/en/ Ministry of Civil Affairs of
B&H, Health Insurance Fund of Federation of B&H; Health Insurance Fund of Republic of Srpska;
Department for Health of Brcko District
No data are available
Source: Czech Statistical Office, Czech Health Accounts.
Source: OECD health database (www.stats.oecd.org).
Source: up to 1997 State Statistical Office. From 1998 National Institute for Health Development.
Pharmaceuticals consumed in hospitals are excluded.
Estonia has provided public pharmaceutical expenditure as % of total pharmaceutical expenditure data
for year 2009-2014.
Source: Social Insurance Institute
Source: Federal Statistical Office, Health Expenditure Accounts.
For years 2009 to 2014 data are provided according to the system of Health Accounts (SHA 2011)
Methodology. GDP estimates refer to ESA 2010 Methodology
Source: National Economic Institute.
Since 2000, is based on updated OECD definitions.
Source: National Accounts, Central Bureau of Statistics.
Source: Istat, National accounts. The OECD definition is applied.
Data for the period 1992-2012 have been estimated on the basis of the updated version of the
classification of economic activities (Ateco 2007, the national version of Nace Rev. 2) and of
products by activity (CPA 2008) and are consistent with the revised time series of national
Source: from 2004 onwards: Central Statistical Office. HC.5.1 x HF.1 data according to OECD SHA
methodology. Since 2013 methodology of SHA2011 is used.
Deviation from the definition: Since 2013 current expenditure on health care is used instead of
total health expenditure.
Source: National Statistics Office (data reviewed from 2001).
Data are not available.
Source of data: Statistics Netherlands: 1972-1997 data: Cost and financing of health care. 1998-
onwards: Health and social care accounts.
Note: The sudden increases and decreases in trend are due to changes in the financing system.
Source of data: National Statistical Institute/OECD Coverage: National
Republic of Moldova
Starting from 2010 calculation of health financing indicators is based on the National Health
Data are not available.
Source of data: NHA data. NHA data received from HIF (Health Insurance Fund)and Drug Agency.
Source of data: Statistical Office of the Republic of Slovenia.
Data are not available.
United Kingdom
Coverage: Data refers to England only.
Deviation from the Definition: Data as at 31st December.